Oxford Cannabinoid shareholders reject investor call to overhaul board

Oxford Cannabinoid Technologies Holdings

06/04/2022 13:44

April 6 (Reuters) - Britain's Oxford Cannabinoid
Technologies  OCTP.L  said on Wednesday shareholders rejected
all resolutions put forward by its third-largest investor to
oust the pharmaceutical company's chief executive officer and
overhaul the board.
    Majority of shareholders who voted at a meeting of
London-listed Oxford Cannabinoid turned down GHS Capital's
proposals. The British company's former non-executive director
Gavin Sathianathan serves as the top boss of U.S.-based GHS.
    Sathianathan in February had called for the removal of six
of Oxford Cannabinoid's directors, including CEO John Lucas and
Chair Julie Pomeroy, and asked for the company to appoint new
members.  urn:newsml:reuters.com:*:nL4N2UT3KU
 

 (Reporting by Sinchita Mitra in Bengaluru; Editing by Amy Caren
Daniel)
 ((Sinchita.Mitra@thomsonreuters.com;))